Angeles Wealth Management’s Coca-Cola KO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Buy
19,251
+2,049
+12% +$155K 0.08% 93
2025
Q4
$1.2M Buy
17,202
+3,242
+23% +$226K 0.07% 121
2025
Q3
$926K Sell
13,960
-1,159
-8% -$79.8K 0.06% 118
2025
Q2
$1.07M Sell
15,119
-138
-0.9% -$9.83K 0.07% 100
2025
Q1
$1.09M Sell
15,257
-18
-0.1% -$1.2K 0.09% 85
2024
Q4
$951K Buy
15,275
+1,556
+11% +$102K 0.08% 93
2024
Q3
$986K Buy
13,719
+560
+4% +$38.3K 0.08% 87
2024
Q2
$838K Buy
13,159
+2,010
+18% +$124K 0.08% 89
2024
Q1
$682K Buy
11,149
+265
+2% +$15.9K 0.07% 99
2023
Q4
$641K Buy
10,884
+1,271
+13% +$72.2K 0.08% 92
2023
Q3
$538K Sell
9,613
-773
-7% -$46.4K 0.08% 88
2023
Q2
$625K Buy
10,386
+36
+0.3% +$2.24K 0.09% 95
2023
Q1
$642K Buy
10,350
+147
+1% +$8.9K 0.1% 98
2022
Q4
$649K Sell
10,203
-2
-0% -$121 0.11% 94
2022
Q3
$572K Sell
10,205
-218
-2% -$13.5K 0.11% 88
2022
Q2
$656K Buy
10,423
+850
+9% +$53.9K 0.13% 82
2022
Q1
$594K Buy
+9,573
New +$582K 0.11% 99

Other funds holding KO

Angeles Wealth Management's KO Position: Q1 2026 in Review

Angeles Wealth Management increased its Coca-Cola (KO) stake by 12% in Q1 2026, buying an estimated $155K and bringing the position to 19,251 shares worth $1.47M. The position accounts for 0.08% of the portfolio, ranked #93.

Angeles Wealth Management first reported a position in KO in Q1 2022 and has held it in 17 quarters since. 3,553 funds tracked by Wall St. Rank hold KO as of Q1 2026.

  • Angeles Wealth Management held 19,251 shares of Coca-Cola worth $1.47M as of Q1 2026.
  • Angeles Wealth Management bought 2,049 Coca-Cola shares in Q1 2026, an estimated $155K.
  • Coca-Cola made up 0.08% of Angeles Wealth Management's portfolio in Q1 2026, its #93 holding.
  • Angeles Wealth Management first reported a position in Coca-Cola in Q1 2022 and has held it in 17 quarters since.
  • 3,553 funds tracked by Wall St. Rank held Coca-Cola as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.